The E2F transcription factors:: key regulators of cell proliferation

被引:201
作者
Müller, H [1 ]
Helin, K [1 ]
机构
[1] Ist Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2000年 / 1470卷 / 01期
关键词
E2F; cell proliferation; cell cycle; pRB; p53; transactivator; transcription; tumor suppressor;
D O I
10.1016/S0304-419X(99)00030-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ever since its discovery, the RE-I gene and the corresponding protein, pRB, have been a focal point of cancer research. The isolation of E2F transcription factors provided the key to our current understanding of RE-I function in the regulation of the cell cycle and in tumor suppression. It is becoming more and more evident that the regulatory circuits governing the cell cycle are very complex and highly interlinked. Certain aspects of RB-1 function, for instance its role in differentiation, cannot be easily explained by the current models of pRB-E2F interaction. One reason is that pRB has targets different from E2F, molecules like MyoD for instance. Another reason may be that we have not completely understood the full complexity of E2F function, itself. In this review, we will try to illuminate the role of E2F in pRB- and p53-mediated tumor suppression pathways with particular emphasis on the aspect of E2F-mediated transcriptional regulation. We conclude that E2F can mediate transcriptional activation as well as transcriptional repression of E2F target genes. The net effect of E2F on the transcriptional activity of a particular gene may be the result of as yet poorly understood protein-protein interactions of E2F with other components of the transcriptional machinery, as well as it may reflect the readout of the different ways of regulating E2F activity, itself. We will discuss the relevance of a thorough understanding of E2F function for cancer therapy. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:M1 / M12
页数:12
相关论文
共 155 条
[1]   DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS [J].
ALMASAN, A ;
YIN, YX ;
KELLY, RE ;
LEE, EYHP ;
BRADLEY, A ;
LI, WW ;
BERTINO, JR ;
WAHL, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5436-5440
[2]   Activation of the human thymidine kinase (TK) promoter by simian virus 40 large T antigen requires both the T antigen pRb family-binding domain and TK promoter sequences resembling E2F-binding sites [J].
Anderson, MM ;
Chen, J ;
Cole, CN ;
Conrad, SE .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6304-6313
[3]   THE RETINOBLASTOMA PROTEIN COPURIFIES WITH E2F-I, AN E1A-REGULATED INHIBITOR OF THE TRANSCRIPTION FACTOR E2F [J].
BAGCHI, S ;
WEINMANN, R ;
RAYCHAUDHURI, P .
CELL, 1991, 65 (06) :1063-1072
[4]   FUNCTIONAL SYNERGY BETWEEN DP-1 AND E2F-1 IN THE CELL CYCLE-REGULATING TRANSCRIPTION FACTOR DRTF1/E2F [J].
BANDARA, LR ;
BUCK, VM ;
ZAMANIAN, M ;
JOHNSTON, LH ;
LATHANGUE, NB .
EMBO JOURNAL, 1993, 12 (11) :4317-4324
[5]   ADENOVIRUS-E1A PREVENTS THE RETINOBLASTOMA GENE-PRODUCT FROM COMPLEXING WITH A CELLULAR TRANSCRIPTION FACTOR [J].
BANDARA, LR ;
LATHANGUE, NB .
NATURE, 1991, 351 (6326) :494-497
[6]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[7]   The retinoblastoma protein pathway and the restriction point [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) :805-814
[8]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[9]   Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins [J].
Beijersbergen, RL ;
Bernards, R .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :103-120
[10]  
Botz J, 1996, MOL CELL BIOL, V16, P3401